Among older adults, metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with increased risk for ...

One of the challenges with liver disease is that it can be a silent threat. In its early stages, it may cause only vague ...

Liver fibrosis, a pathological condition in which the liver becomes stiff and scarred, commonly develops in the progression ...

Imagine a condition affecting nearly one-third of the global population, often silently progressing, and deeply intertwined ...

The Global Liver Institute urges worldwide integration of liver health into diabetes and obesity care as steatotic liver ...

Researchers reaffirmed the need to distinguish between steatotic liver disease subtypes, as some could be tied to especially ...

Discover a study that explored the effects of various metabolic abnormalities, such as central obesity and high blood ...

The drug promotes lipophagy and hepatic fatty acid beta-oxidation to reduce liver fat, inflammation, and liver fibrosis.

Individuals with metabolic dysfunction‐associated steatotic liver disease experience a higher burden of multimorbidity, with ...

Six out of ten people with type 2 diabetes had fatty liver in a new study from . Of these, only a small percentage had ...

A shocking new study shows a significant connection between type 2 diabetes and liver diseases, highlighting the increased ...

Head of the Metabolic Neuroscience Laboratory, investigates the brain ‘goo’ behind obesity and Type-2 diabetes - and how we ...